1. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

   • Sibylle C. Mellinghoff
   • Jens Panse
   • Oliver A. Cornely

   Review Article Open access 07 December 2017 Pages: 197 - 207

2. Current prognostic and predictive factors in follicular lymphoma

   • Marc Sorigue
   • Juan-Manuel Sancho

   Review Article 14 October 2017 Pages: 209 - 227

   

3. PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas

   • Yi Wang
   • Ling Wu
   • Yizhuo Zhang

   Review Article 11 November 2017 Pages: 229 - 237

   

4. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study

   • Luke R. Smart
   • Emmanuela E. Ambrose
   • Patrick T. McGann

   Original Article 16 November 2017 Pages: 239 - 246

   

5. The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes

   • Vu H. Duong
   • Eric Padron
   • Rami S. Komrokji

   Original Article 22 November 2017 Pages: 247 - 254

   

6. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

   • L. E. M. Oosten
   • M. E. D. Chamuleau
   • H. Veelken

   Original Article Open access 06 December 2017 Pages: 255 - 266

   

7. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities

   • Darko Antic
   • Jelena Jelicic
   • Biljana Mihaljevic

   Original Article 12 November 2017 Pages: 267 - 276

   

8. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience

   • Fabienne Widmer
   • Stefan Balabanov
   • Jeroen S. Goede

   Original Article 16 November 2017 Pages: 277 - 287

   

9. Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance

   • Yoshiharu Kusano
   • Masahiro Yokoyama
   • Kiyohiko Hatake

   Original Article 14 November 2017 Pages: 289 - 297

   

10. Pooled analysis of the reports of carfilzomib/ixazomib combinations for relapsed/refractory multiple myeloma

    • Wenjun Xu
    • Xuedong Sun
    • Hui Guo

    Original Article 20 November 2017 Pages: 299 - 307

    

11. Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer

    • Frédérica Schyrr
    • Anita Wolfer
    • Olaia Naveiras

    Original Article Open access 23 November 2017 Pages: 309 - 317

    

12. Infusion of leukocytes from HLA haplo-identical familial donors as an adjuvant in the HLH-2004 protocol to treat the virus-associated adult hemophagocytic lymphohistiocytosis: a retrospective study of 26 patients

    • Hui Zhang
    • Zhiming Dai
    • Wanggang Zhang

    Original Article 12 November 2017 Pages: 319 - 326

    

13. Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major

    • Ardeshir Ghavamzadeh
    • Masoud Sotoudeh
    • Marjan Yaghmaie

    Original Article 17 November 2017 Pages: 327 - 334

    

14. Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

    • Thomas Schroeder
    • Christina Rautenberg
    • Guido Kobbe

    Original Article 18 November 2017 Pages: 335 - 342

    

15. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy

    • Si-Ho Kim
    • Sun Young Cho
    • Jae-Hoon Song

    Original Article 14 November 2017 Pages: 343 - 350

16. HCV load as a possible prognostic factor in patients with HCV-related DLBCL

    • Xiang Zhou
    • Katharina Lisenko
    • Mathias Witzens-Harig

    Letter to the Editor 16 December 2017 Pages: 351 - 354

    

17. PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma

    • Simon Haefliger
    • Michel Bihl
    • Alexandar Tzankov

    Letter to the Editor 03 October 2017 Pages: 355 - 357

    

18. Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma

    • Toyoshi Yanagihara
    • Yuki Ikematsu
    • Yoichi Nakanishi

    Letter to the Editor 02 October 2017 Pages: 359 - 360

    

19. Epstein-Barr virus positive diffuse large B cell lymphoma with G17V RHOA mutation arising from peripheral T cell lymphoma, not otherwise specified

    • Mitsumasa Watanabe
    • Shumpei Mizuta
    • Akira Tamekane

    Letter to the Editor 24 October 2017 Pages: 361 - 362

    

20. Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide

    • Yu-Yan Hwang
    • Rex Au-Yeung
    • Yok-Lam Kwong

    Letter to the Editor 24 October 2017 Pages: 363 - 366

    

21. Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutation

    • Masayuki Kobayashi
    • Kazuaki Yokoyama
    • Arinobu Tojo

    Letter to the Editor 27 September 2017 Pages: 367 - 369

    

22. Systemic trichosporonosis mimicking disseminated varicella zoster viral infection during blinatumomab therapy

    • Thomas S. Y. Chan
    • Yok-Lam Kwong

    Letter to the Editor 14 October 2017 Pages: 371 - 373

    

23. Chemotherapy-related anemia

    • Nathan Visweshwar
    • Michael Jaglal
    • Kenneth Zuckerman

    Letter to the Editor 04 November 2017 Pages: 375 - 376